Differential effects of Ca2 channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes

European Journal of Pharmacology

Volumn 333, Issue 2-3, 1997, Pages 261-268

  Chen, Min ^a   Xiao, Chun Yang ^a   Hashizume, Hiroko ^a   Abiko, Yasushi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Ca2+ channel blocker; Ca2+ overload; Cardiomyocyte; Creatine kinase; Lysophosphatidylcholine

Indexed keywords

BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FLUNARIZINE; LYSOPHOSPHATIDYLCHOLINE; NICARDIPINE; VERAPAMIL; BENZOFURAN DERIVATIVE; CALCIUM; CREATINE KINASE; ETHER DERIVATIVE; FURA 2; SODIUM; SODIUM BINDING BENZOFURAN ISOPHTHALATE; SODIUM CHANNEL; SODIUM-BINDING BENZOFURAN ISOPHTHALATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HEART MUSCLE CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CELL SIZE; DOSE RESPONSE; DRUG EFFECT; HEART; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOFURANS; BEPRIDIL; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL SIZE; CELLS, CULTURED; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHERS, CYCLIC; FLUNARIZINE; FURA-2; HEART; LYSOPHOSPHATIDYLCHOLINES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SODIUM CHANNELS; VERAPAMIL;

EID: 0030608871     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01138-2     Document Type: Article

References (37)

1. Bayer R., Kalusche D., Kaufmann R., Mannhold R. Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 290:1975;81-97.
2. Burnashev N.A., Undrovinas A.I., Fleidervish I.A., Makielski J.C., Rosenshtraukh L.V. Modulation of cardiac sodium channel gating by lysophosphatidylcholine. J. Mol. Cell. Cardiol. 23 (Suppl. I):1991;23-30.
3. 2+ overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes. Br. J. Pharmacol. 118:1996;865-870.
4. 2+-independent cellular injury attenuated by D-propranolol in rat cardiomyocytes. Life Sci. 60:1997;57-62.
5. Corr P.B., Snyder D.W., Lee B.I., Gross R.W., Keim C.R., Sobel B.E. Pathophysiological concentration of lysophosphatides and the slow response. Am. J. Physiol. 243:1982;H187-H195.
6. Diez I., Colom H., Moreno J., Obach R., Peraire C., Domenech J. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci. 80:1991;931-934.
7. Diochot S., Richard S., Baldy-Moulinier M., Nargeot J., Valmier J. Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Q- and R-type calcium currents. Pflug. Arch. 431:1995;10-19.
8. Donck L.V., Pauwels P.J., Vandeplassche G., Borgers M. Isolated rat cardiac myocytes as an experimental model to study calcium overload: The effect of calcium-entry blockers. Life Sci. 38:1986;765-772.
9. Fink K.L., Gross R.W. Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds. Circ. Res. 55:1984;585-594.
10. 2+ antagonists and agonists in rabbit cardiac myocytes. Am. J. Physiol. 260:1991;H1737-H1742.
11. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
12. Hashizume H., Abiko Y. Dilazep and D-propranolol attenuate calcium overload induced by lysophosphatidylcholine in cardiac myocytes. Exp. Clin. Cardiol. 1:1996;45-48.
13. Hashizume H., Akiyama K., Abiko Y. Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes. Eur. J. Pharmacol. 271:1994;1-8.
14. Hoque A.N.E., Hoque N., Hashizume H., Abiko Y. A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart. Jpn. J. Pharmacol. 67:1995;233-241.
15. Janero D.R., Burghardt B., Lopez R. Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists. Biochem. Pharmacol. 37:1989;4197-4203.
16. Katz A.M., Messineo F.C. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ. Res. 48:1981;1-16.
17. Kauder W.F., Watts J.A. Antioxidant properties of dihydropyridines in isolated rat hearts. Biochem. Pharmacol. 51:1996;811-819.
18. Kinnaird A.A.A., Choy P.C., Man R.Y.K. Lysophosphatidylcholine accumulation in the ischemic canine heart. Lipids. 23:1988;32-35.
19. + channels in human uterine leiomyosarcoma cells. Eur. J. Pharmacol. 271:1994;387-393.
20. Levi A.J., Lee C.O., Brooksby P. Properties of the fluorescent sodium indicator 'SBFI' in rat and rabbit cardiac myocytes. J. Cardiovasc. Electrophysiol. 5:1994;241-257.
21. Liu E., Goldhaber J.I., Weiss J.N. Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea-pig ventricular myocytes. J. Clin. Invest. 88:1991;1819-1832.
22. Lundbæk J.A., Andersen O.S. Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers. J. Gen. Physiol. 104:1994;645-673.
23. Mak I.T., Weglicki W.B. Comparative antioxidant activities of propranolol, nifidipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ. Res. 66:1990;1449-1452.
24. Man R.Y.K., Kinnaird A.A.A., Bihler I., Choy P.C. The association of lysophosphatidylchline with isolated cardiac myocytes. Lipids. 25:1990;450-454.
25. Mason R.P., Trumbore M.W. Differential membrane interactions of calcium channel blockers. Biochem. Pharmacol. 51:1996;653-660.
26. 2+ channel inhibitory effects of cibenzoline with verapamil on guinea-pig heart. Gen. Pharmacol. 22:1991;87-91.
27. Nasa Y., Ichihara K., Abiko Y. Both D-cis- and L-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart. J. Pharmacol. Exp. Ther. 255:1990;680-689.
28. 2+ current in guniea-pig heart. Br. J. Pharmacol. 113:1994;451-456.
29. Pang D.C., Sperelakis N. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities. Biochem. Pharmacol. 33:1984;821-826.
30. 3H ]Batrachotoxinin A 20-α-benzoate binding to sodium channels in rat brain: Characterization and pharmacological significance Eur. J. Pharmacol. 124:1986;291-298.
31. ++ channels. J. Pharmacol. Exp. Ther. 255:1990;1117-1122.
32. Sato T., Kiyosue T., Arita M. Inhibition effects of palmitoylcarnitine and lysophosphatidylcholine on the sodium current of cardiac ventricular cells. Pflug. Arch. 420:1992;94-100.
33. Sperelakis N., Pappano A.J. Increase in PNa and PK of cultured heart cells produced by veratridine. J. Gen. Physiol. 53:1969;97-114.
34. Tytgat J., Vereecke J., Carmeliet E. A combined study of sodium current and T-type calcium current in isolated cardiac cells. Pflug. Arch. 417:1990;142-148.
35. Watts J.A., Whipple J.P., Hatley A.A. A low concentration of nisoldipine reduces ischemic heart injury: Enhanced reflow and recovery of contractile function without energy preservation during ischemia. J. Mol. Cell. Cardiol. 19:1987;809-817.
36. Woodley S.L., Ikenouchi H., Barry W.H. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J. Mol. Cell. Cardiol. 23:1991;671-680.
37. Yatani A., Brown A.M., Schwartz A. Bepridil block of cardiac calcium and sodium Channels. J. Pharmacol. Exp. Ther. 237:1986;9-17.